TGF-β requires CTLA-4 early after T cell activation to induce foxP3 and generate adaptive CD4+CD25+ regulatory cells

Journal of Immunology

Volumn 176, Issue 6, 2006, Pages 3321-3329

  Zheng, Song Guo ^a   Wang, Ju Hua ^a   Stohl, William ^a   Kim, Kyoung Soo ^a   Gray, J Dixon ^a   Horwitz, David A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; KNOCKOUT MOUSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; TIME SERIES ANALYSIS;

EID: 33644835247     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.6.3321     Document Type: Article

References (63)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
2. Shevach, E. M. 2004. Regulatory/suppressor T cells in health and disease. Arthritis Rheum. 50: 2721-2724.
3. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
4. + T and NK cells. J. Exp. Med. 180: 1937-1942.
5. + regulatory T cells from human peripheral blood. J. Immunol. 166: 7282-7289.
6. +CD25 precursors. J. Immunol. 169: 4183-4189.
7. + regulatory T cells generated ex vivo with IL-2 and TGF-β suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 172: 1531-1539.
8. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
9. - precursors. Am. J. Transplant. 4: 1614-1627.
10. Rao, P. E., A. L. Petrone, and P. D. Ponath. 2005. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β. J. Immunol 174: 1446-1455.
11. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol 172: 5149-5153.
12. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J. Immunol. 172: 5213-5221.
13. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
14. Tai, X., M. Cowan, L. Feigenbaum, and A. Singer. 2005. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6: 152-162.
15. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182: 459-465.
16. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1: 405-413.
17. Chambers, C. A., M. S. Kuhns, J. G. Egen, and J. P. Allison. 2001. CTLA-4 mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 19: 565-594.
18. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541-547.
19. Stohl, W., D. Xu, K. S. Kim, C. S. David, and J. P. Allison. 2004. MHC class II-independent and -dependent T cell expansion and B cell hyperactivity in vivo in mice deficient in CD152 (CTLA-4). Int. Immunol. 16: 895-904.
20. Masteller, E. L., E. Chuang, A. C. Mullen, S. L. Reiner, and C. B. Thompson. 2000. Structural analysis of CTLA-4 function in vivo. J. Immunol. 164: 5319-5327.
21. Riley, J. L., and C. H. June. 2005. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 105: 13-21.
22. Grohmann, U., C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M. L. Belladonna, R. Bianchi, M. C. Fioretti, and P. Puccetti. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3: 1097-1101.
23. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M. L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212.
24. + T cells. J. Exp. Med. 188: 1849-1857.
25. Sullivan, T. J., J. J. Letterio, A. van Elsas, M. Mamura, J. van Amelsfort, S. Sharpe, B. Metzler, C. A. Chambers, and J. P. Allison. 2001. Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc. Natl. Acad. Sci. USA 98: 2587-2592.
26. Egen, J. G., and J. P. Allison. 2002. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16: 23-35.
27. Pentcheva-Hoang, T., J. G. Egen, K. Wojnoonski, and J. P. Allison. 2004. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21: 401-413.
28. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-310.
29. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
30. Tivol, E. A., and J. Gorski. 2002. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4. J. Immunol. 169: 1852-1858.
31. + regulatory T cell function. Eur. J. Immunol. 34: 2996-3005.
32. Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774.
33. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
34. + T regulatory cells. Nat. Immunol. 4: 337-342.
35. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
36. L induction. J. Immunol. 160: 12-15.
37. + regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA 101: 4572-4577.
38. - T cells. Int. Immunol 16: 1203-1213.
39. Zheng, Y., C. N. Manzotti, M. Liu, F. Burke, K. I. Mead, and D. M. Sansom. 2004. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172: 2778-2784.
40. + regulatory T cells. Eur. J. Immunol 32: 2888-2896.
41. Paust, S., L. Lu, N. McCarty, and H. Cantor. 2004. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA 101: 10398-10403.
42. Kündig, T. M., A. Shahinian, K. Kawai, H. W. Mittrücker, E. Sebzda, M. F. Bachmann, T. W. Mak, and P. S. Ohashi. 1996. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5: 41-52.
43. Gett, A. V., F. Sallusto, A. Lanzavecchia, and J. Geginat. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4: 355-360.
44. + T cell activation by dendritic cells in lymph nodes. J. Exp. Med. 200: 847-856.
45. Chikuma, S., A. K. Abbas, and J. A. Bluestone. 2005. B7-independent inhibition of T cells by CTLA-4. J. Immunol. 175: 177-181.
46. high T regulatory cells with target (allo)antigen specificity. J. Immunol. 173: 2866-2876.
47. Jovasevic, V. M., L. Gorelik, J. A. Bluestone, and M. B. Mokyr. 2004. Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity. J. Immunol. 172: 1449-1454.
48. + regulatory T cells. Int. Immunol 16: 1643-1656.
49. Letterio, J. J. 2005. TGF-β signaling in T cells: roles in lymphoid and epithelial neoplasia. Oncogene 24: 5701-5712.
50. Wenner, C. E., and S. Yan. 2003. Biphasic role of TGF-β1 in signal transduction and crosstalk. J. Cell. Physiol. 196: 42-50.
51. Piek, E., and A. B. Roberts. 2001. Suppressor and oncogenic roles of transforming growth factor-β and its signaling pathways in tumorigenesis. Adv. Cancer Res. 83: 1-54.
52. Elliott, M. R., R. A. Shanks, I. U. Khan, J. W. Brooks, P. J. Burkett, B. J. Nelson, V. Kyttaris, Y.-T. Juang, G. C. Tsokos, and G. M. Kammer. 2004. Down-regulation of IL-2 production in T lymphocytes by phosphorylated protein kinase A-RIIβ. J. Immunol. 172: 7804-7812.
53. Gray, J. D., T. Liu, N. Huynh, and D. A. Horwitz. 2001. Transforming growth factor β enhances the expression of CD154 (CD40L) and production of tumor necrosis factor α by human T lymphocytes. Immunol. Lett. 78: 83-88.
54. + T cells. J. Immunol. 175: 1483-1490.
55. + T lymphocytes. J. Immunol. 169: 6231-6235.
56. + regulatory T cells by inhibition of APC proteosome function. J. Immunol. 174: 2787-2795.
57. Kim, H.-P., B.-G. Kim, J. Letterio, and W. J. Leonard. 2005. Smad-dependent cooperative regulation of interleukin-2 receptor α chain gene expression by T cell receptor and TGF-β. J. Biol. Chem. 280: 34042-34047.
58. Malek, T. R. 2003. The main function of IL-2 is to promote the development of T regulatory cells. J. Leukocyte Biol. 74: 961-965.
59. Nelson, B. H. 2002. Interleukin-2 signaling and the maintenance of self-tolerance. Curr. Dir. Autoimmun. 5: 92-112.
60. Kremer, J. M., M. Dougados, P. Emery, P. Durez, J. Sibilia, W. Shergy, S. Steinfeld, E. Tindall, J. C. Becker, T. Li, et al. 2005. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 52: 2263-2271.
61. Guo, L., M. Fujino, H. Kimura, N. Funeshima, Y. Kitazawa, Y. Harihara, K. Tezuka, M. Makuuchi, S. Suzuki, and X. K. Li. 2003. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation. Transpl. Immunol. 12: 41-48.
62. Eagar, T. N., N. J. Karandikar, J. A. Bluestone, and S. D. Miller. 2002. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur. J. Immunol. 32: 972-981.
63. + cells in the recipient. Int. Immunol. 18: 279-289.